Cooper Companies (COO) Other Non-Current Assets (2009 - 2026)
Cooper Companies (COO) posted Other Non-Current Assets of $672.8 million for Q2 2026, down 2.27% on a QoQ basis from $688.4 million in Q1 2026, and up 2.09% year-over-year from $659.0 million in Q2 2025.
Analysis
Cooper Companies (COO) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Cooper Companies has reported Other Non-Current Assets for 18 years, with the latest figure at $672.8 million in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 2.09% year-over-year to $672.8 million in Q2 2026; TTM through Apr 2026 was $672.8 million, a 2.09% increase from a year earlier, with the FY2025 full-year figure at $689.2 million, up 4.33% from the prior year.
- Other Non-Current Assets was $672.8 million for Q2 2026 at Cooper Companies, down from $688.4 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $689.2 million in Q4 2025, with the low at $169.0 million in Q1 2022.
- Average Other Non-Current Assets over 5 years is $575.6 million, with a median of $632.6 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 236.57% in 2023, then retreated 1.08% in 2024.
- Over 5 years, Other Non-Current Assets stood at $587.9 million in 2022, then advanced by 8.37% to $637.1 million in 2023, then advanced by 3.69% to $660.6 million in 2024, then rose by 4.33% to $689.2 million in 2025, then fell by 2.38% to $672.8 million in 2026.
- The last three Other Non-Current Assets figures came in at $672.8 million (Q2 2026), $688.4 million (Q1 2026), and $689.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn | 672.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 672.80 Mn |
| Jan 31, 2026 | 688.40 Mn |
| Oct 31, 2025 | 689.20 Mn |
| Jul 31, 2025 | 653.30 Mn |
| Apr 30, 2025 | 659.00 Mn |
| Jan 31, 2025 | 663.70 Mn |
| Oct 31, 2024 | 660.60 Mn |
| Jul 31, 2024 | 621.40 Mn |
| Apr 30, 2024 | 637.20 Mn |
| Jan 31, 2024 | 616.90 Mn |
| Oct 31, 2023 | 637.10 Mn |
| Jul 31, 2023 | 628.20 Mn |
| Apr 30, 2023 | 584.80 Mn |
| Jan 31, 2023 | 568.80 Mn |
| Oct 31, 2022 | 587.90 Mn |
| Jul 31, 2022 | 306.00 Mn |
| Apr 30, 2022 | 317.40 Mn |
| Jan 31, 2022 | 169.00 Mn |
| Oct 31, 2021 | 401.20 Mn |
| Jul 31, 2021 | 117.20 Mn |